NASDAQ: MRVI Q3 2025 Financial Results November 6, 2025 Agenda | | Welcome | Deb Hart, Head of Investor Relations | | --- | --- | --- | | 02 | Business Updates | Bernd Brust, Chief Executive Officer | | 03 | Financial Results and Guidance | Raj Asarpota, Chief Financial Officer | | 04 | Q&A Session | Bernd Brust, Chief Executive Officer Raj Asarpota, Chief Financial Officer Chanfeng Zhao, Chief Scientific Officer | | 01 | | | © 2025 Maravai LifeSciences 2 Past performance may not be a reliable indicator of ...